Diabetes Clinical Trials in San Francisco

Showing 401-420 of 453 trials

Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus

NCT00889486

The purpose of this study is to evaluate the effect of TZP-102 on gastric emptying rate, gastroparesis symptoms and health-related quality of life in diabetic patients with gastroparesis.

GastroparesisDiabetes Mellitus

Tranzyme, Inc.92 participantsStarted Apr 2009

Long Beach, California, United States • Los Angeles, California, United States • San Francisco, California, United States +20 more locations

COMPLETEDPhase 2< 1 mile

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

NCT00476931

The purpose of the study is to study the clinical effects of the investigational drug, SB-509 versus placebo in patients with diabetic neuropathy.

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy

Sangamo Therapeutics91 participantsStarted May 2007

La Jolla, California, United States • Lakewood, California, United States • Lomita, California, United States +17 more locations

Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Diabetes Trials in Other Cities

Automated Telephone Nutrition Support

Follow-Up Study for Exubera

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes

Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509

Mechanisms of Glucose Lowering Effect of Colesevelam HCl

A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control

Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia

WelChol® and Insulin in Treating Patients With Type 2 Diabetes

Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy

A Study for Patients With Type 2 Diabetes Mellitus

An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance

Screening for Early Evidence of Diabetes

Testing the Developmental Origins Hypothesis

Other Conditions in San Francisco